Clinical Trials Directory

Trials / Completed

CompletedNCT04874753

The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Uşak University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (\> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Detailed description

The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.

Conditions

Interventions

TypeNameDescription
OTHERchange in kidney function and proteinuriachange in eGFR nad proteinuria in patients with chronic kidney disease

Timeline

Start date
2020-11-03
Primary completion
2020-12-01
Completion
2021-01-01
First posted
2021-05-06
Last updated
2021-05-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04874753. Inclusion in this directory is not an endorsement.